Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
Objective: Distinguishing immune-related adverse events (irAEs) caused by immune checkpoint inhibitors (ICIs) from the AEs caused by chemotherapy, targeted therapy, or infection is highly difficult. This study offers new insights into evaluating the diagnosis, differential diagnostic, and prognostic...
Saved in:
Main Authors: | Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu, Xiubao Ren |
---|---|
Format: | article |
Language: | EN |
Published: |
China Anti-Cancer Association
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/1f35fc1f305e4dacbf38d508d4a1651f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DETERMINATION OF DIAGNOSTIC ACCURACY OF BIOCHEMICAL PARAMETERS (CRP, LDH & FERRITIN) IN THE DIAGNOSIS OF COVID-19 IN SUSPECTED COVID CASES
by: Tayyaba Ashiq, et al.
Published: (2021) -
Possible effect of decreased insulin resistance on ferritin levels after Nordic Walking training
by: Ilhan B, et al.
Published: (2016) -
Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
by: Di Wang, et al.
Published: (2021) -
Extraction and purification of Ferritin from liver tissue
by: R Behjati Ardakani, et al.
Published: (2005) -
Alterations of the serum and CSF ferritin levels and the diagnosis and prognosis of amyotrophic lateral sclerosis
by: Parastou Paydarnia, et al.
Published: (2021)